Dados B3 › Restatements
Has PROFARMA DISTRIB PROD FARMACEUTICOS S.A. (PFRM3) ever restated its financial statements? In which years?
Yes: the statements for 2010, 2012, 2013, 2019, 2021 came back with different figures in the following year's annual filing — 19 account(s) in all, each below with both values.
| Year | Account | Aggregation | As first filed | As restated | Difference | Revealed in (CVM file) |
|---|---|---|---|---|---|---|
| 2010 | transactions with shareholders (DMPL 5.04) | consolidated | R$ -861 k | R$ 133 k | 115.4% | DFP 2011 · 26/03/2013 |
| 2010 | income taxes (DRE 3.08) | consolidated | R$ -5.6 m | R$ -3.8 m | 32.4% | DFP 2011 · 26/03/2013 |
| 2010 | profit before taxes (DRE 3.07) | consolidated | R$ 40.0 m | R$ 33.8 m | 15.4% | DFP 2011 · 26/03/2013 |
| 2010 | net income plus OCI (DMPL 5.05) | consolidated | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | profit in the statement of changes in equity (DMPL 5.05.01) | consolidated | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | profit from continuing operations (DRE 3.09) | consolidated | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | net profit (DRE 3.11) | consolidated | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | profit attributable to controlling shareholders (DRE 3.11.01) | consolidated | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | operating profit (EBIT) (DRE 3.05) | consolidated | R$ 68.6 m | R$ 62.5 m | 9.0% | DFP 2011 · 26/03/2013 |
| 2010 | equity (BPP 2.03) | consolidated | R$ 518.9 m | R$ 508.4 m | 2.0% | DFP 2011 · 26/03/2013 |
| 2010 | closing equity (DMPL 5.07) | consolidated | R$ 518.9 m | R$ 508.4 m | 2.0% | DFP 2011 · 26/03/2013 |
| 2010 | opening equity (DMPL 5.03) | consolidated | R$ 485.4 m | R$ 478.2 m | 1.5% | DFP 2011 · 26/03/2013 |
| 2010 | current liabilities (BPP 2.01) | consolidated | R$ 432.3 m | R$ 434.5 m | 0.5% | DFP 2011 · 26/03/2013 |
| 2012 | cost of goods and services (DRE 3.02) | consolidated | R$ -3.60 bn | R$ -3.03 bn | 15.8% | DFP 2013 · 31/03/2014 |
| 2012 | net revenue (DRE 3.01) | consolidated | R$ 3.80 bn | R$ 3.23 bn | 15.0% | DFP 2013 · 31/03/2014 |
| 2013 | gross profit (DRE 3.03) | consolidated | R$ 307.5 m | R$ 430.1 m | 28.5% | DFP 2014 · 29/06/2018 |
| 2013 | cost of goods and services (DRE 3.02) | consolidated | R$ -3.16 bn | R$ -3.04 bn | 3.9% | DFP 2014 · 29/06/2018 |
| 2019 | net operating cash flow (DFC_MI 6.01) | consolidated | R$ 126.9 m | R$ 127.6 m | 0.5% | DFP 2020 · 16/03/2021 |
| 2021 | net income plus OCI (DMPL 5.05) | consolidated | R$ 73.8 m | R$ 68.6 m | 7.1% | DFP 2022 · 17/10/2023 |
How it is detected: each year appears twice at the CVM — in its own annual filing and as the comparative in the next one. A difference above 0.5% in a key account is recorded, never corrected silently. Only the aggregation the site publishes (consolidated, or individual when the company does not consolidate) counts. “No value in the file” means the account came empty (zero) in that CVM file. Descriptive, not investment advice.
PFRM3 — company page · all restatements in the base
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:15 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:15 UTC. If this does not match /saude, you are reading a cached copy.